强力定眩片联合前列地尔治疗脑供血不足性眩晕症临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R255.3

基金项目:


Clinical Study on Qiangli Dingxuan Tablets Combined with Alprostadil for Vertigo Symptom Due to Insufficiency of Cerebral Blood Supply
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察强力定眩片联合前列地尔治疗脑供血不足性眩晕症的临床疗效及对血流动力学的影 响。方法:选取198 例脑供血不足性眩晕症患者为研究对象,采用随机数字表法分为对照组和观察组各 99 例。对照组给予前列地尔注射液治疗,观察组在对照组基础上加用强力定眩片口服,2 组疗程均为2 周。 比较2 组临床疗效、不良反应以及治疗前后中医证候评分、颈性眩晕症状与功能评估量表(ESCV) 评分、椎 动脉型颈椎病功能评定量表(FS-CSA) 评分及血流动力学指标。结果:观察组总有效率为90.91%,高于对照 组80.81%(P<0.05)。治疗后,2 组各项中医证候评分较治疗前降低(P<0.05);且观察组各项中医证候评分 低于对照组(P<0.05)。治疗后,2 组ESCV 评分较治疗前升高,FS-CSA 评分较治疗前降低(P<0.05);且观 察组ESCV 评分高于对照组,FS-CSA 评分低于对照组(P<0.05)。治疗后,2 组椎动脉和基底动脉血流速 度(Vm) 升高,脉动指数(PI) 下降(P<0.05);且观察组椎动脉和基底动脉Vm 高于对照组,PI 低于对照 组(P<0.05)。结论:强力定眩片联合前列地尔治疗脑供血不足性眩晕症可改善患者临床症状,提高患者生活 质量,改善血流动力学指标。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the therapy of Qiangli Dingxuan Tablets combined with Alprostadil on vertigo symptom due to insufficiency of cerebral blood supply and its effect on hemodynamics. Methods: A total of 198 patients with vertigo symptom due to insufficiency of cerebral blood supply were selected as research objects and divided into the control group and the observation group according to the random number table method,with 99 cases in each group. The control group was given Alprostadil Injection,and the observation group was additionally treated with oral use of Qiangli Dingxuan Tablets on the basis of the treatment of the control group. Both groups were treated for 2 weeks. The clinical effects and adverse reactions in the two groups were compared. Before and after treatment, the changes in the traditional Chinese medicine (TCM) syndrome scores, hemodynamic indexes, scores of Evaluation Scale for Cervical Vertigo (ESCV) and functional scale for cervical spondylosis of vertebral artery type (FS-CSA) were also compared in the two groups. Results:The total effective rate was 90.91% in the observation group,which was higher than that of 80.81% in the control group (P<0.05). After treatment, the TCM syndrome scores in both groups were decreased when compared with those before treatment (P< 0.05);the TCM syndrome scores in the observation group were lower than those in the control group (P< 0.05). After treatment,the ESCV scores in the two groups were higher than those before treatment,and the FS-CSA scores in the two groups were lower than those before treatment (P<0.05);the ESCV score in the observation group was higher than that in the control group,and the FS-CSA score was lower than that in the control group (P<0.05). After treatment,the levels of mean velocity (Vm) of the vertebral artery and the basilar artery in both groups were increased when compared with those before treatment,and the levels of pulse index (PI) were decreased (P<0.05); the levels of Vm of the vertebral artery and basilar artery in the observation groups were higher than those in the control group,and the PI was lower than that in the control group (P<0.05). Conclusion: The therapy of Qiangli Dingxuan Tablets combined with Alprostadil can relieve the clinical symptoms in patients with vertigo symptom due to insufficiency of cerebral blood supply,improve the quality of life,and regulate the hemodynamic indexes.

    参考文献
    相似文献
    引证文献
引用本文

吴春雷,娄轶群,泮飞虎.强力定眩片联合前列地尔治疗脑供血不足性眩晕症临床研究[J].新中医,2023,55(3):74-77

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-02-17
  • 出版日期:
文章二维码